Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats

Vascular Pharmacology

Volumn 51, Issue 2-3, 2009, Pages 205-213

  Song, Ming Bao ^a   Yu, Xue Jun ^a   Zhu, Guang Xu ^b   Chen, Jian Fei ^a   Zhao, Gang ^a   Huang, Lan ^a  

^a Xinqiao Hospital   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Arterial injury; Endothelial progenitor cells; Gene transfer; Hepatocyte growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BLOOD VESSEL INJURY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; ENDOTHELIUM CELL; FEASIBILITY STUDY; GENE TARGETING; GENETIC TRANSFECTION; HYPERCHOLESTEROLEMIA; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RISK FACTOR; STEM CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; BONE MARROW CELLS; CARDIOVASCULAR DISEASES; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL, DIETARY; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFECTION; TUNICA INTIMA;

EID: 68249105287     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.06.009     Document Type: Article

References (41)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4 (2003) 915-925
3. Bruno S., Bussolati B., Scacciatella P., Marra S., Sanavio F., Tarella C., and Camussi G. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine 34 (2006) 56-65
4. Campagnolo L., Leahy A., Chitnis S., Koschnick S., Fitch M.J., Fallon J.T., Loskutoff D., Taubman M.B., and Stuhlmann H. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am. J. Pathol. 167 (2005) 275-284
5. Cho H.J., Kim H.S., Lee M.M., Kim D.H., Yang H.J., Hur J., Hwang K.K., Oh S., Choi Y.J., Chae I.H., Oh B.H., Choi Y.S., Walsh K., and Park Y.B. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108 (2003) 2918-2925
6. Condon E.T., Wang J.H., and Redmond H.P. Surgical injury induces the mobilization of endothelial progenitor cells. Surgery 135 (2004) 657-661
7. Del Papa N., Quirici N., Soligo D., Scavullo C., Cortiana M., Borsotti C., Maglione W., Comina D.P., Vitali C., Fraticelli P., Gabrielli A., Cortelezzi A., and Lambertenghi-Deliliers G. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 54 (2006) 2605-2615
8. Dimmeler S., and Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J. Mol. Med. 82 (2004) 671-677
9. Duan H.F., Wu C.T., Wu D.L., Lu Y., Liu H.J., Ha X.Q., Zhang Q.W., Wang H., Jia X.X., and Wang L.S. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol. Ther. 8 (2003) 467-474
10. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90 (2002) E89-93
11. Fadini G.P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., Grego F., Vigili de Kreutzenberg S., Tiengo A., Agostini C., and Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2140-2146
12. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., Girardi L., Yurt R., Himel H., and Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res. 88 (2001) 167-174
13. Griese D.P., Achatz S., Batzlsperger C.A., Strauch U.G., Grumbeck B., Weil J., and Riegger G.A. Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells. Cardiovasc. Res. 58 (2003) 469-477
14. Hayashi K., Nakamura S., Morishita R., Moriguchi A., Aoki M., Matsumoto K., Nakamura T., Kaneda Y., Sakai N., and Ogihara T. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther. 7 (2000) 1664-1671
15. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., Crystal R.G., Besmer P., Lyden D., Moore M.A., Werb Z., and Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
16. Hibbert B., Olsen S., and O'Brien E. Involvement of progenitor cells in vascular repair. Trends Cardiovasc. Med. 13 (2003) 322-326
17. Hunting C.B., Noort W.A., and Zwaginga J.J. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization. Vox Sang. 88 (2005) 1-9
18. Ieda Y., Fujita J., Ieda M., Yagi T., Kawada H., Ando K., and Fukuda K. G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J. Mol. Cell. Cardiol. 42 (2007) 540-548
19. Ishizawa K., Kubo H., Yamada M., Kobayashi S., Suzuki T., Mizuno S., Nakamura T., and Sasaki H. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem. Biophys. Res. Commun. 324 (2004) 276-280
20. Kawamoto A., and Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter. Cardiovasc. Interv. 70 (2007) 477-484
21. Keymel S., Kalka C., Rassaf T., Yeghiazarians Y., Kelm M., and Heiss C. Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res. Cardiol. 103 (2008) 582-586
22. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
23. Leor J., Guetta E., Feinberg M.S., Galski H., Bar I., Holbova R., Miller L., Zarin P., Castel D., Barbash I.M., and Nagler A. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 24 (2006) 772-780
24. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., and Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
25. Ma H., Calderon T.M., Fallon J.T., and Berman J.W. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 164 (2002) 79-87
26. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
27. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
28. Schuster M.D., Kocher A.A., Seki T., Martens T.P., Xiang G., Homma S., and Itescu S. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am. J. Physiol., Heart Circ. Physiol. 287 (2004) H525-532
29. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., Pittenger M.F., and Martin B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73 (2002) 1919-1925 (discussion 1926)
30. Shoji M., Sata M., Fukuda D., Tanaka K., Sato T., Iso Y., Shibata M., Suzuki H., Koba S., Geshi E., and Katagiri T. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc. Pathol. 13 (2004) 306-312
31. Son B.R., Marquez-Curtis L.A., Kucia M., Wysoczynski M., Turner A.R., Ratajczak J., Ratajczak M.Z., and Janowska-Wieczorek A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24 (2006) 1254-1264
32. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., Matsumoto K., Nakamura T., Kaneda Y., and Ogihara T. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107 (2003) 1411-1417
33. Trusolino L., and Comoglio P.M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev., Cancer 2 (2002) 289-300
34. Umemura T., Soga J., Hidaka T., Takemoto H., Nakamura S., Jitsuiki D., Nishioka K., Goto C., Teragawa H., Yoshizumi M., Chayama K., and Higashi Y. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am. J. Hypertens. 21 (2008) 1203-1209
35. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95 (2004) 343-353
36. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-7
37. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 257-266
38. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., and Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93 (2003) e17-e24
39. Yang H., Magilnick N., Noureddin M., Mato J.M., and Lu S.C. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J. Cell. Physiol. 210 (2007) 766-773
40. Zhang W., and Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12 (2002) 9-18
41. Zhou Y.J., Wang J.H., and Zhang J. Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis. Biochem. Biophys. Res. Commun. 344 (2006) 658-666